BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16755595)

  • 1. Patent foramen ovale closure in older patients: have we been barking up the wrong tree?
    Block PC
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):143-4. PubMed ID: 16755595
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcatheter closure of patent foramen ovale in older adults.
    Kiblawi FM; Sommer RJ; Levchuck SG
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):136-42; discussion 143-4. PubMed ID: 16755591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Percutaneous closure of patent foramen ovale, as secondary prevention of cryptogenic cerebral event].
    Temesvári A; Bálint OH; Liptai C; Kancz S; Németh B; Szatmári A
    Orv Hetil; 2006 Oct; 147(42):2035-9. PubMed ID: 17165604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
    Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
    Harms V; Reisman M; Fuller CJ; Spencer MP; Olsen JV; Krabill KA; Gray WA; Jesurum JT
    Am J Cardiol; 2007 May; 99(9):1312-5. PubMed ID: 17478164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptogenic stroke patients with patent foramen ovale should be closed only in the setting of a randomized control trial.
    Felberg RA
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):4-5. PubMed ID: 17173277
    [No Abstract]   [Full Text] [Related]  

  • 7. Percutaneous devices for stroke prevention.
    Bayard YL; Ostermayer SH; Hein R; Skowasch M; Büscheck F; Baranowski A; Heinisch C; Sievert H
    Cardiovasc Revasc Med; 2007; 8(3):216-25. PubMed ID: 17765654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On horse sense and horse feathers: an argument against insistence on enrolling cryptogenic stroke patients with patent foramen ovale in randomized clinical trials.
    Kramer P
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):1-3. PubMed ID: 17173276
    [No Abstract]   [Full Text] [Related]  

  • 9. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous closure of patent foramen ovale and the risk of atrial fibrillation.
    Bhindi R
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):301; author reply 302. PubMed ID: 20049956
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.
    Spies C; Khandelwal A; Timmermanns I; Schräder R
    Am J Cardiol; 2008 Oct; 102(7):902-6. PubMed ID: 18805119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closure of patent foramen ovale: The abolition of stroke and asymptotic realities.
    Tan WA
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):517-8. PubMed ID: 15274164
    [No Abstract]   [Full Text] [Related]  

  • 13. [Patent foramen ovale and cryptogenic stroke: role of interventional hemodynamics].
    Carminati M
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):707-8. PubMed ID: 12497808
    [No Abstract]   [Full Text] [Related]  

  • 14. PFO closure for prevention of recurrent stroke in patients after cryptogenic stroke: the imperative of completing randomized controlled trials.
    Kaplan AV; Lukovits TG; Robb JF
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):6-8. PubMed ID: 17173274
    [No Abstract]   [Full Text] [Related]  

  • 15. Case study: closure of a patent foramen ovale without surgery following stroke.
    Duff D
    Axone; 2007; 28(2):42-3. PubMed ID: 17460958
    [No Abstract]   [Full Text] [Related]  

  • 16. Patent foramen ovale.
    Fu YC; Hijazi ZM
    Expert Rev Cardiovasc Ther; 2005 Sep; 3(5):875-8. PubMed ID: 16181032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patent foramen ovale and stroke].
    Meier JM; Delabays A; Girod G; Eeckhout E
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):987-93. PubMed ID: 16008176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Patent foramen ovale. What is it and what does it indicate?].
    Serena J
    Neurologia; 2006 Dec; 21(10):689-94. PubMed ID: 17106821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent foramen ovale closure and subsequent atrial fibrillation.
    Tobis J
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):896. PubMed ID: 19902510
    [No Abstract]   [Full Text] [Related]  

  • 20. Specifics of patent foramen ovale.
    Mas JL
    Adv Neurol; 2003; 92():197-202. PubMed ID: 12760183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.